Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018; Massachusetts Medical Society; Volume: 380; Issue: 1 Linguagem: Inglês
10.1056/nejmoa1812792
ISSN1533-4406
AutoresDeepak L. Bhatt, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Craig Granowitz, Jean‐Claude Tardif, Christie M. Ballantyne,
Tópico(s)Lipoproteins and Cardiovascular Health
ResumoPatients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are needed to determine its effects on ischemic events.
Referência(s)